Cardiologist Philippe Généreux spoke to Cardiovascular Business about the highly anticipated PROGRESS trial. "What we learned from this trial is that moderate aortic stenosis should not be seen anymore as a benign entity," he said. 

More and more clinicians are using advanced CCTA technologies to diagnose, treat and manage patients with suspected coronary artery disease. An upcoming webinar will include a deep dive into that very topic, highlighting why the modality is such a game-changer for patient care. 

Contego Medical secured the new approvals after the FDA reviewed positive data from the PERFORMANCE III IDE study.

The Massachusetts clinician went missing after going on an afternoon bike ride. Authorities found his body the following day.

While quality-of-life improvements were seen in patients with regular chest pain, an invasive treatment strategy was not associated with a significant improvement in survival compared to patients treated more conservatively. 

The UltiSynq defibrillation lead from Abbott gives clinicians a new option for left bundle branch area pacing. The device has also received CE mark approval.

A new AI-powered voice analysis system is much more accurate than the current standard of care, according to new data presented at AHA Scientific Sessions 2026. The technology was specifically built to be user-friendly, requiring patients to speak just a handful of sentences into their smartphone each day. 

The big question on everyone's mind: Why was this trial neutral when the drug was so effective at reducing Lp(a) levels?

The Shockwave C2 Aero Fly Coronary IVL Catheter from Johnson & Johnson MedTech is now available. In addition, the company announced, the next-generation device will be featured in its booth at TCT 2026. 

ASNC focuses on selecting the appropriate examination for each patient rather than treating one modality as universally preferable. At the same time, cardiac PET has been linked to key benefits that could improve patient care if only more clinicians could use it. ASNC's next president, Andrew Einstein, MD, PhD, discussed this and more in a new interview.

“Instead of asking only whether a patient will survive, we need to ask whether they will be able to maintain the life they value after discharge,” one researcher explained.

The acquisition of Millennium Health was first announced last month, but now the details have been finalized. Labcorp said its new subsidiary, which works in the field of pain management and patient monitoring, will be fully integrated into its existing network of diagnostic centers.

The increase in remote work highlights how significantly the geography of radiology has changed.